MNX internals
| ||||||||||||||||||||||||||||
| Parent-child relations graph |
|
|||||||||||||||||||||||||||
| Identifier | Description |
|---|---|
CHEBI:88431 chebi:88431 URHLXWKKSRFRJJ-RLMMGFKESA-N | Cer(d18:0/18:1(11Z)) (11Z)-N-[(2S,3R)-1,3-dihydroxyoctadecan-2-yl]octadec-11-enamide |
| hmdb:HMDB0011762 URHLXWKKSRFRJJ-RLMMGFKESA-N | Cer(d18:0/18:1(11Z)) (11Z)-N-[(2S,3R)-1,3-Dihydroxyoctadecan-2-yl]octadec-11-enimidate (11Z)-N-[(2S,3R)-1,3-dihydroxyoctadecan-2-yl]octadec-11-enamide Ceramide Ceramide(D18:0/18:1(11Z)) N-(11Z-Octadecenoyl)-D-erythro-sphinganine N-(11Z-Octadecenoyl)-dihydrosphingosine N-(11Z-Octadecenoyl)-sphinganine |
vmhM:dhcrm_asclp vmhM:dhcrm_asclp vmhmetabolite:dhcrm_asclp vmhmetabolite:dhcrm_asclp URHLXWKKSRFRJJ-RLMMGFKESA-N | Dihydroceramide (D18:1/18:1(11Z)) (11Z)-N-[(2S,3R)-1,3-Dihydroxyoctadecan-2-yl]octadec-11-enimidate Cell signaling agent Cellular membrane Ceramide Ceramide(D18:0/18:1(11Z)) Chaos Dietary supplement Digestion Extracellular region Fauna Inflammation agent Inner membrane Insulin resistance Insulin resistance syndrome Lipid metabolic process Membrane integrity agent Membrane stability agent Metabolic syndrome x N-(11Z-Octadecenoyl)-D-erythro-sphinganine N-(11Z-Octadecenoyl)-dihydrosphingosine N-(11Z-Octadecenoyl)-sphinganine Necrotic cell death Necrotic process Nutraceutical Reaven's syndrome Signal transduction Signaling agent Signalling molecule Surface-active agent Syndrome x Type i pcd Type ii pcd |
SLM:000395523 slm:000395523 URHLXWKKSRFRJJ-RLMMGFKESA-N | N-(11Z-octadecenoyl)-sphinganine Cer(d18:0/18:1(11Z)) Ceramide (d18:0/18:1(11Z)) |
hmdb:HMDB11762 vmhM:dhcrm_181_11Z vmhM:dhcrm_181_11Z vmhM:M_dhcrm_asclp | secondary/obsolete/fantasy identifier |